DnB Asset Management
DXCM icon

DnB Asset Management’s DexCom DXCM Stock Holding History

DnB Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84.5M Buy
1,255,284
+81,198
+7% +$5.41M 0.24% 63
2026
Q1 		$73.7M Sell
1,174,086
-95,305
-8% -$6.64M 0.26% 61
2025
Q4 		$84.2M Buy
1,269,391
+170,847
+16% +$11M 0.29% 51
2025
Q3 		$73.9M Buy
1,098,544
+803,086
+272% +$63.6M 0.28% 60
2025
Q2 		$25.8M Buy
295,458
+5,747
+2% +$450K 0.11% 143
2025
Q1 		$19.8M Buy
289,711
+43,326
+18% +$3.54M 0.09% 162
2024
Q4 		$19.2M Buy
246,385
+23,914
+11% +$1.77M 0.08% 175
2024
Q3 		$14.9M Buy
222,471
+78,279
+54% +$6.43M 0.07% 199
2024
Q2 		$16.3M Buy
144,192
+44,752
+45% +$5.66M 0.08% 174
2024
Q1 		$13.8M Sell
99,440
-10,221
-9% -$1.28M 0.07% 193
2023
Q4 		$13.6M Sell
109,661
-467
-0.4% -$47.7K 0.07% 210
2023
Q3 		$10.3M Buy
110,128
+40,333
+58% +$4.55M 0.06% 222
2023
Q2 		$8.97M Sell
69,795
-298
-0.4% -$36K 0.05% 253
2023
Q1 		$8.14M Buy
70,093
+3,464
+5% +$388K 0.05% 260
2022
Q4 		$7.55M Buy
66,629
+2,651
+4% +$291K 0.05% 270
2022
Q3 		$5.15M Sell
63,978
-754
-1% -$63.9K 0.04% 327
2022
Q2 		$4.82M Buy
64,732
+2,488
+4% +$227K 0.03% 341
2022
Q1 		$7.96M Buy
62,244
+3,744
+6% +$410K 0.05% 288
2021
Q4 		$7.85M Buy
58,500
+2,252
+4% +$324K 0.05% 281
2021
Q3 		$7.69M Buy
56,248
+1,588
+3% +$200K 0.05% 263
2021
Q2 		$5.83M Sell
54,660
-10,660
-16% -$1.02M 0.04% 339
2021
Q1 		$5.87M Buy
65,320
+18,944
+41% +$1.78M 0.04% 278
2020
Q4 		$4.29M Buy
46,376
+3,252
+8% +$290K 0.04% 298
2020
Q3 		$4.44M Buy
43,124
+2,916
+7% +$305K 0.05% 244
2020
Q2 		$4.08M Buy
+40,208
New +$3.6M 0.05% 237
2020
Q1 		– Sell
-40,748
Closed -$2.23M – 616
2019
Q4 		$2.23M Buy
+40,748
New +$1.93M 0.02% 433

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DnB Asset Management's DXCM Position: Q2 2026 in Review

DnB Asset Management increased its DexCom (DXCM) stake by 6.9% in Q2 2026, buying an estimated $5.41M and bringing the position to 1,255,284 shares worth $84.5M. The position accounts for 0.24% of the portfolio, ranked #63.

DnB Asset Management first reported a position in DXCM in Q4 2019 and has held it in 26 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • DnB Asset Management held 1,255,284 shares of DexCom worth $84.5M as of Q2 2026.
  • DnB Asset Management bought 81,198 DexCom shares in Q2 2026, an estimated $5.41M.
  • DexCom made up 0.24% of DnB Asset Management's portfolio in Q2 2026, its #63 holding.
  • DnB Asset Management first reported a position in DexCom in Q4 2019 and has held it in 26 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.